Mokhtari Dowlatabad Hadi, Mamdouh Amir, Yousefpour Narges, Mahdavi Reihane, Zandi Ashkan, Hoseinpour Parisa, Moosavi-Kiasari Seyed Mohammad Sadegh, Abbasvandi Fereshte, Kordehlachin Yasin, Parniani Mohammad, Mohammadpour-Aghdam Karim, Faranoush Pooya, Foroughi-Gilvaee Mohammad Reza, Abdolahad Mohammad
Nano Bioelectronics Devices Lab, Cancer Electronics Research Group, School of Electrical and Computer Engineering, Faculty of Engineering, University of Tehran, Tehran 14399-57131, Iran.
Department of Pathology, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran 15179-64311, Iran.
Diagnostics (Basel). 2023 Jan 4;13(2):179. doi: 10.3390/diagnostics13020179.
A gigahertz (GHz) range antenna formed by a coaxial probe has been applied for sensing cancerous breast lesions in the scanning platform with the assistance of a suction tube. The sensor structure was a planar central layer and a metallic sheath of size of 3 cm connected to a network analyzer (keySight FieldFox N9918A) with operational bandwidth up to 26.5 GHz. Cancer tumor cells have significantly higher water content (as a dipolar molecule) than normal breast cells, changing their polarization responses and dielectric losses to incoming GHz-based stimulation. Principal component analysis named , related to the dispersion ratio of the input signal, is used as a parameter to identify malignant tumor cells in a mouse model (in vivo) and tumor specimens of breast cancer patients (in vitro) (both central and marginal parts). The results showed that values in the frequency range from 5 to 6 GHz were significantly higher in cancer-involved breast lesions. Histopathological analysis was the gold standard for achieving the calibration to distinguish normal from cancerous lesions. Our calibration on tumor specimens presented 82% positive predictive value (PPV), 100% negative predictive value (NPV), and 86% accuracy. Our goal is to apply this system as an in vivo non-invasive tumor margin scanner after further investigations in the future.
一种由同轴探头构成的千兆赫兹(GHz)频段天线,在吸管的辅助下,已被应用于扫描平台中对乳腺癌病变进行传感检测。该传感器结构为一个平面中央层和一个尺寸为3厘米的金属护套,连接至一台工作带宽高达26.5 GHz的网络分析仪(是德科技FieldFox N9918A)。癌肿瘤细胞(作为一种偶极分子)的含水量显著高于正常乳腺细胞,这改变了它们对基于GHz的入射刺激的极化响应和介电损耗。名为 的主成分分析,与输入信号的色散比相关,被用作一个参数,以识别小鼠模型(体内)和乳腺癌患者的肿瘤标本(体外)(中央和边缘部分)中的恶性肿瘤细胞。结果显示,在涉及癌症的乳腺病变中,5至6 GHz频率范围内的 值显著更高。组织病理学分析是实现区分正常与癌性病变的 校准的金标准。我们对肿瘤标本的校准呈现出82%的阳性预测值(PPV)、100%的阴性预测值(NPV)和86%的准确率。我们的目标是在未来进一步研究后,将该系统用作体内非侵入性肿瘤边缘扫描仪。